Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

NNNNAnbio Biotechnology

Nasdaq · CIK 0001982708
Filer categoryNon-accelerated filer<br>Emerging growth company
Entity typeother
SIC2835 In Vitro & In Vivo Diagnostic Substances
FY end1231
XBRL facts81

Identity from submissions API

NameAnbio Biotechnology
CIK0001982708
TickersNNNN
ExchangesNasdaq
Entity typeother
CategoryNon-accelerated filer<br>Emerging growth company
SIC2835 In Vitro & In Vivo Diagnostic Substances
EIN000000000
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone4916096247281
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
FRIEDRICH-EBERT-ANLAGE 49
FRANKFURT AM MAIN
2M
60308
Germany
Mailing address
FRIEDRICH-EBERT-ANLAGE 49
FRANKFURT AM MAIN
2M
60308
Germany

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

43 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-07-09 F-3ASR AUTOMATIC SHELF REGISTRATION STATEMENT OF SECURITIES OF WELL-KNOWN SEASONED ISSU 0001185185-26-002869 333-297349 261166035 33 2143027 1 1
2026-06-12 3 xslF345X06/ownership.xml 0001185185-26-002487 3180
2026-06-12 3 xslF345X06/ownership.xml 0001185185-26-002486 3164
2026-05-19 6-K FORM 6-K 0001185185-26-001897 001-42526 26995746 34 426952
2026-04-27 6-K FORM 6-K 0001185185-26-001504 001-42526 26901448 34 761656
2026-04-09 20-F/A FORM 20-F/A1 0001185185-26-001313 001-42526 26849720 34 274842 1 1
2026-04-08 3 xslF345X06/ownership.xml 0001185185-26-001311 3162
2026-04-08 3 xslF345X06/ownership.xml 0001185185-26-001310 3174
2026-04-08 3 xslF345X06/ownership.xml 0001185185-26-001308 3168
2026-04-08 3 xslF345X06/ownership.xml 0001185185-26-001307 3165
2026-04-08 3 xslF345X06/ownership.xml 0001185185-26-001306 3153
2026-04-07 20-F FORM 20-F 0001185185-26-001294 001-42526 26845105 34 4222023 1 1
2026-02-17 6-K FORM 6-K 0001185185-26-000588 001-42526 26642240 34 63583
2026-01-26 6-K FORM 6-K 0001185185-26-000269 001-42526 26558374 34 45734
2025-12-30 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-126654 001-42526 251614654 34 53660
2025-11-13 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-109447 001-42526 251474884 34 30888
2025-04-28 20-F ANNUAL REPORT 0001213900-25-035802 001-42526 25876296 34 4623291 1 1
2025-02-21 6-K REPORT OF FOREIGN PRIVATE ISSUER 0001213900-25-016129 001-42526 25652672 34 235790
2025-02-19 424B4 PROSPECTUS 0001213900-25-015001 333-284106 25637084 33 6246562
2025-02-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000497 333-284106 25637042 33 1750
2025-02-18 CERT 8A_Cert_NNNN.pdf 0001354457-25-000115 001-42526 25633557 34 761258
2025-02-14 CORRESP filename1.htm 0001213900-25-014006 8024
2025-02-14 CORRESP filename1.htm 0001213900-25-014005 6442
2025-02-14 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-25-013885 001-42526 25624386 34 14516
2025-02-10 F-1/A REGISTRATION STATEMENT 0001213900-25-011623 333-284106 25604672 33 163247
2025-01-24 F-1/A REGISTRATION STATEMENT 0001213900-25-006373 333-284106 25552811 33 169670
2025-01-22 FWP FREE WRITING PROSPECTUS 0001213900-25-005105 333-284106 25543464 34 20515769
2025-01-10 F-1/A REGISTRATION STATEMENT 0001213900-25-002551 333-284106 25522207 33 6749177
2024-12-31 F-1 REGISTRATION STATEMENT 0001213900-24-114129 333-284106 241593804 33 7536728
2024-12-11 DRSLTR filename1.htm 0001213900-24-107617 21284
2024-12-11 DRS/A filename1.htm 0001213900-24-107614 377-07031 241540054 33 6452764
2024-12-04 UPLOAD filename1.pdf 0000000000-24-013358 377-07031 46495
2024-11-18 DRS/A filename1.htm 0001213900-24-099679 377-07031 241472030 33 6457648
2024-07-01 DRSLTR filename1.htm 0001213900-24-057662 12941
2024-07-01 DRS/A filename1.htm 0001213900-24-057659 377-07031 241089116 33 5287621
2024-06-21 UPLOAD filename1.pdf 0000000000-24-007087 377-07031 45643
2024-06-10 DRS/A filename1.htm 0001213900-24-050933 377-07031 241031364 33 5388487
2024-06-07 DRSLTR filename1.htm 0001213900-24-050934 108086
2024-03-22 UPLOAD filename1.pdf 0000000000-24-003186 377-07031 75229
2024-03-11 DRS/A filename1.htm 0001213900-24-021163 377-07031 24736253 33 6181479
2024-03-08 DRSLTR filename1.htm 0001213900-24-021166 88676
2024-01-23 UPLOAD filename1.pdf 0000000000-24-000910 377-07031 93627
2023-12-27 DRS filename1.htm 0001213900-23-098831 377-07031 231517689 33 6100369

Latest XBRL company facts

One latest value per concept from companyfacts (81 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
ffd NetFeeAmt NetFeeAmt USD 0 2026-07-03 F-3ASR 2026-07-09 0001185185-26-002869
ffd TtlFeeAmt TtlFeeAmt USD 0 2026-07-03 F-3ASR 2026-07-09 0001185185-26-002869
ffd TtlOfferingAmt TtlOfferingAmt USD 0 2026-07-03 F-3ASR 2026-07-09 0001185185-26-002869
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-03 F-3ASR 2026-07-09 0001185185-26-002869
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 0 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 104,979 2024-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 3.66M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 3.66M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 87,836 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 6.56M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap Assets Assets USD 30.24M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap AssetsCurrent Assets, Current USD 30.24M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 7.77M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 7.77M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -3.99M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount HKD 500,000 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap CashUninsuredAmount Cash, Uninsured Amount USD 7.35M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap CostOfRevenue Cost of Revenue USD 1.10M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 387,440 2024-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 1,294 2024-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 1,293 2023-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.147 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.147 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap FederalDepositInsuranceCorporationPremiumExpense Federal Deposit Insurance Corporation Premium Expense USD 250,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 493,562 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap GrossProfit Gross Profit USD 7.54M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 6.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.63M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 2.59M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap IncreaseDecreaseInDepositOtherAssets Increase (Decrease) in Deposit Assets USD 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -353,872 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -18,311 2022-01-01 2022-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -17,143 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 581,466 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 8.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 7,999 2022-01-01 2022-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap InterestIncomeOther Interest Income, Other USD 337,101 2024-01-01 2024-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 142,023 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap Liabilities Liabilities USD 87,836 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 30.24M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap LiabilitiesCurrent Liabilities, Current USD 87,836 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 6.95M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -4.20M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -6.74M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 6.40M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 635,723 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap OperatingExpenses Operating Expenses USD 1.78M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 5.77M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 12,059 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap OtherAssetsCurrent Other Assets, Current USD 14.08M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 87,836 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 138 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 24,312 2024-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap OtherReceivableAfterAllowanceForCreditLossNoncurrent OtherReceivableAfterAllowanceForCreditLossNoncurrent USD 18,009 2023-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 948 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 282,550 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 35.47M 2024-01-01 2024-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 19.42M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 607,072 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 606,124 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 7.23M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 35.80M 2024-01-01 2024-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap ProceedsFromSaleOfShortTermInvestments Proceeds from Sale of Short-term Investments USD 15.22M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD -68,003 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 201,305 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 23.58M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 8.65M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap Revenues Revenues USD 8.65M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 18,311 2022-01-01 2022-12-31 2024 FY 20-F 2025-04-28 0001213900-25-035802
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 1.57M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap ShortTermInvestments Short-term Investments USD 4.13M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 30.16M 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 6.56M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 10,000 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationForfeited Shares Issued, Value, Share-based Payment Arrangement, Forfeited USD 0 2023-01-01 2023-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 43.67M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 43.67M 2025-01-01 2025-12-31 2025 FY 20-F 2026-04-07 0001185185-26-001294

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →